Alnylam Pharmaceuticals Inc (ALNY) Stock Forecast & Predictions

Alnylam Pharmaceuticals Inc ALNY: $135.13

675 W Kendall St, Cambridge, Massachusetts, US. | Sector: Manufacturing | Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET) | Web: https://www.alnylam.com/

  • Market Cap$16.29B
  • Change (52 Weeks)0.29%
  • Low (52 Weeks)$119.29
  • Alnylam Pharmaceuticals Inc (ALNY) Forecast Based on Technical Analysis


    Neutral
    Based on 16 Technical Indicators where 18.75% are on Buy, 31.25% on Sell, and 50.00% Neutral.

    According to the market data, Alnylam Pharmaceuticals Inc (ALNY) stock price is $135.13 and the 52 weeks low is $119.29, which means the Alnylam Pharmaceuticals Inc stock price is up 0.29% in the last 12 months.

    Alnylam Pharmaceuticals Inc (ALNY) Stock Price is not Trending currently as per the Weekly Chart, which means the price may range between specific high and low levels for the next few months, unless some significant changes take place in the market performance or news.

    Technical Indicators are algorithms that are used mostly by Technical traders to predict the price action of a stock.

    Based on our analysis of 16 technical indicators, 18.75% are indicating that ALNY Stock price might rise further, 31.25% indicating that ALNY Stock price might fall, and 50.00% are in a neutral position.

    Based on these technical algorithms, overall ALNY stock price has a Neutral Signal, which means the stock price has the potential to move either up or down, depending on the nature of consolidating market phase, since majority of indicators are providing a neutral signal.

    Alnylam Pharmaceuticals Inc (ALNY) Stock Forecast By Analysts


    Strong Buy
    Analysts Recommendations for Alnylam Pharmaceuticals Inc (ALNY) is based on 28 Institutional Analyst Ratings where 42.86% are on Strong Buy, 21.43% on Moderate Buy, 35.71% remains on Hold, 0.00% are on Moderate Sell and 0.00% are on Strong Sell.

    Out of 28 Institutional Analysts, majority recommended ALNY stock as Strong Buy. Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of Alnylam Pharmaceuticals Inc.

    Alnylam Pharmaceuticals Inc (ALNY) Stock Price Prediction By Analysts


    HighLowAverage
    $246.75$88.88$178.75
    $178.7532.28% Upside
    Updated: 2021-04-12 00:00:00

    The Average Price target for ALNY set by the institutional analysts is $178.75 where High Estimate is $246.75, Median $184.11 and Low $88.88.

    The average price target for ALNY by Institutional Analysts is $178.75, which is 32.28% Upside from the current price. So according to the Institutional Analysts, ALNY Stock might be a bit undervalued at this stage and there’s potential for upside.

    However, although Institutional Analysts set their price targets after extensive research, they’re not always correct. After all, the market is mostly driven by investors speculation and emotion than just concrete numbers.

    Alnylam Pharmaceuticals Inc (ALNY) Stock Forecast Based on News Sentiment


    Neutral
    Based on 3 articles published Last Week, where 50.00% are Bullish and 50.00% are Bearish.

    According to the news articles published last week, journalists and bloggers had a mixed sentiment of ALNY consisting of positive and negative, it shows that Alnylam Pharmaceuticals Inc had a neutral news coverage.

    Neutral news coverage usually doesn't affect short-term price of a stock, so ALNY stock price most likey won't have any reaction to last weeks news coverage.

    Alnylam Pharmaceuticals Inc (ALNY) Stock Forecasts By Institutional Analysts


    Analyst
    Recommendation
    Action
    GuggenheimNeutralDowngraded
    NeedhamBuyMaintained
    Morgan StanleyOverweightMaintained
    HC Wainwright & Co.BuyMaintained
    CitigroupNeutralDowngraded
    BarclaysOverweightMaintained
    BMO CapitalMarket PerformDowngraded
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyOverweightMaintained
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyOverweightMaintained
    B of A SecuritiesBuyMaintained
    CitigroupBuyInitiated
    OppenheimerPerformDowngraded
    SVB LeerinkMarket PerformMaintained
    Morgan StanleyOverweightMaintained
    Morgan StanleyOverweightMaintained
    UBSNeutralMaintained
    RBC CapitalSector PerformInitiated
    OppenheimerOutperformMaintained
    Morgan StanleyOverweightMaintained
    JP MorganNeutralDowngraded
    BMO CapitalOutperformMaintained
    BarclaysOverweightMaintained
    NeedhamBuyMaintained
    NomuraReduceMaintained
    BerenbergBuyInitiated
    NomuraReduceMaintained
    Morgan StanleyOverweightMaintained
    Chardan CapitalBuyMaintained
    Cantor FitzgeraldOverweightReiterated
    Morgan StanleyOverweightMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyOverweightMaintained
    Cantor FitzgeraldOverweightMaintained
    BMO CapitalOutperformMaintained
    BarclaysOverweightMaintained
    OppenheimerOutperformInitiated
    Bank of AmericaBuyInitiated
    UBSNeutralMaintained
    Piper JaffrayOverweightMaintained
    Morgan StanleyOverweightMaintained
    BMO CapitalOutperformMaintained
    Stifel NicolausBuyMaintained
    Cantor FitzgeraldOverweightMaintained
    BMO CapitalOutperformMaintained
    Evercore ISI GroupOutperformInitiated
    SVB LeerinkMarket PerformMaintained
    BMO CapitalOutperformMaintained
    Morgan StanleyOverweightUpgraded
    UBSNeutralInitiated
    GuggenheimBuyInitiated
    Leerink SwannMarket PerformInitiated
    BMO CapitalOutperformMaintained
    Cantor FitzgeraldOverweightInitiated
    Morgan StanleyEqual-WeightMaintained
    Stifel NicolausBuyMaintained
    Stifel NicolausBuyMaintained
    NomuraReduceMaintained
    Morgan StanleyEqual-WeightMaintained
    Cowen & Co.OutperformMaintained
    BMO CapitalOutperformMaintained
    B. Riley FBRBuyMaintained
    Stifel NicolausBuyUpgraded
    Morgan StanleyEqual-WeightMaintained
    Morgan StanleyEqual-WeightMaintained
    Stifel NicolausHoldMaintained
    BMO CapitalOutperformMaintained
    Evercore ISI GroupIn-LineInitiated
    Credit SuisseOutperformMaintained
    Morgan StanleyEqual-WeightMaintained
    BMO CapitalOutperformMaintained
    Leerink SwannMarket PerformMaintained
    Morgan StanleyEqual-WeightMaintained
    JP MorganOverweightUpgraded
    BarclaysOverweightMaintained
    B. Riley FBRBuyMaintained
    B. RileyBuyMaintained
    Credit SuisseOutperformMaintained
    FBR CapitalBuyMaintained
    FBR CapitalBuyInitiated
    Goldman SachsBuyUpgraded
    BMO CapitalOutperformMaintained
    NeedhamBuyMaintained
    Morgan StanleyEqual-WeightMaintained
    Leerink SwannMarket PerformMaintained
    Credit SuisseOutperformMaintained
    BarclaysOverweightMaintained
    NomuraReduceInitiated
    BMO CapitalOutperformMaintained
    Morgan StanleyEqual-WeightMaintained
    BarclaysEqual-WeightMaintained
    BernsteinOutperformInitiated
    Morgan StanleyEqual-WeightMaintained
    BMO CapitalOutperformInitiated
    UBSNeutralInitiated
    Ladenburg ThalmannBuyInitiated
    Morgan StanleyEqual-weightDowngraded
    Stifel NicolausHoldMaintained
    Leerink SwannMarket PerformDowngraded
    JefferiesBuyMaintained
    Goldman SachsNeutralMaintained
    Credit SuisseOutperformMaintained
    BarclaysEqual-weightDowngraded
    Janney CapitalNeutralInitiated
    JP MorganOverweightMaintained
    JefferiesBuyMaintained
    Morgan StanleyOverweightInitiated
    Leerink SwannOutperformMaintained
    Chardan CapitalBuyInitiated
    JP MorganOverweightUpgraded
    JMP SecuritiesMarket OutperformMaintained
    Leerink SwannOutperformMaintained
    Credit SuisseOutperformInitiated
    Leerink SwannOutperformMaintained
    JefferiesBuyInitiated
    Leerink SwannOutperformMaintained
    FBR CapitalOutperformInitiated
    JP MorganNeutralMaintained
    PiperJaffrayOutperformMaintained
    Janney CapitalInitiated
    BarclaysOverweightInitiated
    Cowen & Co.OutperformInitiated
    Deutsche BankMaintained
    JP MorganOverweightMaintained
    S&P Capital IQBuyUpgraded
    Morgan StanleyEqual-weightDowngraded
    S&P Capital IQHoldDowngraded
    Morgan StanleyOverweightMaintained
    Deutsche BankBuyMaintained
    Leerink SwannOutperformMaintained
    PiperJaffrayOverweightMaintained
    JP MorganOverweightMaintained
    Morgan StanleyOverweightInitiated
    Morgan StanleyOverweightInitiated
    Deutsche BankBuyInitiated
    McNicoll Lewis VlakHoldDowngraded
    JMP SecuritiesMarket OutperformInitiated
    PiperJaffrayOverweightMaintained
    PiperJaffrayOverweightUpgraded
    PiperJaffrayNeutralMaintained
    PiperJaffrayNeutralDowngraded
    S&P Capital IQBuyUpgraded
    PiperJaffrayOverweightMaintained
    McNicoll Lewis VlakBuyMaintained
    JP MorganOverweightInitiated

    Alnylam Pharmaceuticals Inc (ALNY) Stock Earning Per Share (EPS) Forecast / Estimate


    $-1.682
    The average consensus EPS for ALNY is $-1.682 with a high estimate of $-1.113 and Low of $-1.999 for the period 2021-06-30 and based on 21 Institutional Analysts.

    Last Quarter


    Actual
    Estimate
    Date
    $-2.18$-1.69149662020-09-30


    The latest average Earning Per Share Estimate for Alnylam Pharmaceuticals Inc is $-1.68, which is higher than ALNY's last EPS, $-2.18. This means that Analysts are expecting Alnylam Pharmaceuticals Inc to report higher earnings. This can drive share prices higher since the investors have positive sentiment about market performance of Alnylam Pharmaceuticals Inc.

    Earning Per Share (EPS) History


    Actual
    Estimate
    Date
    $-2.18$-1.69149662020-09-30
    $-1.56$-1.77104640000000012020-06-30
    $-1.83$-1.93200242020-03-31
    $-2.57$-2.26800059999999972019-12-31
    $-1.92$-2.08379880000000032019-09-30
    $-1.93$-1.89911762019-06-30
    $-1.73$-2.11076760000000042019-03-31
    $-2.09$-2.256242018-12-31
    $-2.43$-2.02615862018-09-30
    $-1.83$-1.79012018-06-30
    $-1.41$-1.49625842018-03-31
    $-1.48$-1.41561722017-12-31
    $-1.34$-1.28711762017-09-30
    $-1.34$-1.24631762017-06-30
    $-1.25$-1.28435339999999992017-03-31
    $-1.32$-1.36131239999999992016-12-31
    $-1.21$-1.16044380000000012016-09-30
    $-1.05$-1.26572822016-06-30
    $-1.21$-1.072022016-03-31
    $-1.07$-0.97478340000000012015-12-31
    $-0.91$-0.93245340000000012015-09-30
    $-0.85$-0.7594412015-06-30
    $-0.62$-0.66812015-03-31
    $-0.28$-0.6107252014-12-31
    $-0.58$-0.64430342014-09-30
    $-0.58$-0.558962014-06-30
    $-0.39$-0.548252014-03-31
    $-0.51$-0.4592013-12-31
    $-0.48$-0.39488282013-09-30
    $-0.29$-0.353603399999999962013-06-30
    $-0.16$-0.29288282013-03-31
    $-0.46$-1.45520342012-12-31
    $-0.38$-0.31622012-09-30
    $-0.25$-0.196352012-06-30
    $-0.25$-0.367199999999999972012-03-31
    $-0.33$-0.33092882011-12-31
    $-0.31$-0.3582752011-09-30
    $-0.33$-0.367199999999999972011-06-30
    $-0.38$-0.303082800000000042011-03-31
    $-0.16$-0.359552010-12-31

    What is Analyst Ratings & Price Targets?

    The analysts provide Buy, Sell or Hold ratings after extensive research of a companies financial reports, listening to conference calls and some of them even get in contact with upper management of the company to get an overall picture of operation.

    Although institutional Analyst’s are not always correct, their ratings are followed by millions of traders around the world and they can heavily influence trading activities for a company.

    As a retail investor, going through analyst ratings will instantly provide you an idea if the stock is worth buying. Top Analysts also provide their price targets. It’s a prediction of where the stock price might go based on their analysis.

    The best way to analyze price targets is to combined average price targets of major analysts. If the average price target is much higher than the current price of the stock, then the probability of a stock going up is also high.

    What is Technical Analysis?

    Technical Analysis refers to analyzing a stock's price over a period of time. In the financial market, past price patterns are one of the strongest indicators of an asset's future performance.

    In easier terms, millions of traders use Live Charts to watch the stock prices, it is actually a single source of truth for most traders. When a stock's price reaches a significant price level/pattern in the chart, millions of traders take buy/sell positions from those levels.

    As a regular investor, one of the easiest ways to check technical analysis of a stock is through Technical Indicators. Technical Indicators are programmed algorithms that monitor price changes in the Charts and indicate Buy/Sell based on market conditions.

    Some Technical Indicators can be very powerful (e.g SMA) and some can be pretty useless. Stock research tools like iTradely heavily simplify the technical analysis process for the investors by showing Buy/Sell/Neutral ratings combined from 17 powerful technical indicators, all in one page.

    What is Earnings Per Share (EPS) and Why is it Important?

    EPS, or Earning Per Share, can tell a lot about a stock’s performance. It’s calculated by dividing a company’s profit by the number of outstanding shares of its common stocks.

    In layman’s term, earnings is an indicator of a company’s profitability. Higher the earnings, the more profitable a company is.
    Some traders pick stocks solely based on EPS or earnings Analysis, it is a very powerful indicator of a stock’s price.

    Before you buy a stock, check the company’s earnings History and Surprises. A Surprise happens when a company reports a much higher or lower actual earnings/EPS than the forecasted earnings/EPS.

    If a company reports higher EPS surprises consistently, analysts keep raising their estimates, traders become more confident in the company, driving the share price higher.

    What is Stock Sentiment?

    Stock Sentiment refers to how people speculating about the stock or what kind of trading position investors are often taking.

    There are different kinds of sentiments you can find online for a company, this includes Investor Sentiment (Percentage of investors buying or selling), News Sentiment (Is the company getting positive or negative impressions from the Press?), Social Sentiment (The overall trends about the company in social media, is it negative or positive?).